Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clinuvel, Inc.
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients with a confirmed diagnosis of generalized vitiligo with VASI≥3 of the body and VASI on the head and neck ≥0.3 including an F-VASI≥0.1
Stable or active vitiligo
Aged 12 or more
Fitzpatrick skin types III-VI
You may not be if
Fitzpatrick skin types I-II
Extensive leukotrichia
Treatment with NB-UVB phototherapy in the last three months prior to study start
Allergy to afamelanotide or the polymer contained in the implant
Any other treatment for vitiligo within 30 days prior to the Screening Visit
History of melanoma or lentigo maligna
History of dysplastic nevus syndrome
Any malignant skin lesions
Presence of severe hepatic disease or hepatic impairment
Female who is pregnant or lactating
Female of child-bearing potential not using adequate contraceptive measures
Sexually active man with a partner of child-bearing potential who is not using adequate contraceptive measures
Use of any prior and concomitant therapy which may interfere with the objective of the study
Extensive tattoos
Clareo Health | A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
